chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Syncope 5 minutes post GARDASIL administration. Jerking movements, urinated during LOC. Entire incident lasted 8-10min. MD was called and attended to patient. Patient was observed for 30 min post incident and sent home.
3/26/21 Presents to ER with complaint of "cough x3 weeks after choking on some coffee with progressive shortness of breath"  Wife reports O2 sat of 88% prior to coming to ER. HX of CAD, hyperlipidemia, COPD. Follows a pulmonologist. Scope was done after "choking" incident which was negative. Pulmonologist though maybe he had Pulmonary Fibrosis. Patient never heard anything back. Cough and Shortness of breath got progressively worse and came to ER. Patient is positive for pulmonary emboli, was admitted to the hospital, and is receiving Eliquis.
vertigo; blood pressure a little bit higher; This is a spontaneous report from a contactable consumer or non health care professional. A 61-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FC3180), dose 1 via an unspecified route of administration on 12Aug2021 Thursday (Age at vaccination: 61 years) as dose 1, single for covid-19 immunisation. Medical history included ongoing hypertension Verbatim: High Blood Pressure. Concomitant medications included Low dose high blood pressure pill. Prior vaccinations within 4 weeks were None. Reporter states that her husband takes this on an as needed basis. The patient experienced vertigo and blood pressure a little bit higher (condition aggravated) on 13Aug2021. Reporter wants to know if these symptoms are associated with Pfizer COVID-19 vaccine. Reporter says that her husband blood pressure has been fluctuating since before the vaccine; but since the vaccine it has been higher. Patient was taking low dose high blood pressure pill. The outcome of the events was not recovered.
Patient experienced a syncopal event roughly 5 minutes after the requisite 15 minute observational period.  Patient stabilized; symptoms resolved with standard supportive care.
My arm is red and tender.  The doctor gave me a prescription for Triamcinolone Acetonide Cream to put on the site 3 times a day.
Unexpected side effects or adverse reactions from intake of Paxvolib slept six days solid- from Tuesday 6 p.m.  5/31/22 at 6 p.m. until Monday June 6th mid midmorning could not spell week of Monday June 6th after I "woke up"
Cognitive impairment (brain fog): trouble focusing, putting together complex sentences, writing, lost words mid sentence. Took 3 days to pass  Rash and itching at the injection site developed 4 days after shot, passed after 2 days
Many hives clustered on left side of abdomen 2 were 1 1/4 inches in size (felt very hyper) some on inner thigh, ankle right leg. About 12 total.
Fever, followed by emesis, and then brief seizure 3:00 PM next day (12/17/2009)
Pt developed chills, temp 101 degrees and vomiting x 2 hours and the pt felt tired but symptoms resolved per wife.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2021-395985 (Patient Link).
24 hours after receiving the Pneumonia vaccine she developed hives at the injection site & redness that traveled down to her elbow.  She also developed fever, chills & body aches.
Hives over all of body, face, chest included. Itching.  Followed by flu symptoms.
"Throat closing" - itching, hives - Lot# 092040D  exp02/2011 Westward epinephrine 5.3 cc SC @ 10:30 AM (R) forearm- 11:15 AM spoke to Doctor's office  - to see Pt @ 1:45 PM
rash was on her back; had pain in her arm; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL1284 and expiry date was not reported), via an unspecified route of administration, on 16Jan2021 (age at vaccination: 70 years), as a single dose for COVID-19 immunization. The patient's medical history included eats eggs like maybe for a couple days she will have a rash on the back. Concomitant medications were not reported. The re-porter said she had the vaccination COVID 19 vaccine on the 16Jan2021 and did nothing and then the next day on 17Jan2021, she had pain in her arm for like 5 minutes and that was it, the second one was a different story. That day she had a rash on her back and she forgot to tell the person she had rash on her back and she took the thing and she went about her day. No further information provided. The next day her arm hurt a little and it hurt on the other arm, in the same place. She did not know if it was sympathetic pain or what but both arms hurt in the muscle towards the back. The rash was on her back rash before the second dose, sometimes when she eats eggs like maybe for a couple days she will have a rash on the back and she had that but it was drying out, she meant to tell the guy and she didn't ask about it, she was rushed it was a rainy day, she had to drive the interstate which was busy and they had to stand under an awning to keep from getting wet, she thought she lost some of her senses and forgot to tell him. She thought the little rash got dark red after the vaccine and she has never had that happen it is usually a little pink thing she does not know if it would be called hives but after the vaccine she got she thinks it was the day after or 2 days after, she didn't recall but the rash intensified it was a dark red color but it was an individual thing there was like 2 that were bigger and very dark red. The patient underwent lab test and procedure included labs work with unknown result on an unspecified date in Feb2021 and weight was 148lbs sometimes it fluctuates to 150lbs on an unspecified date. Outcome of the event had pain in her arm was recovered on 17Jan2021 and for another event, it was unknown.  No follow-up attempts are possible. No further information is expected.
Chronic headaches/ migraines right temple- since receiving vaccine about 5 times plus per week
Sore of throat for for 2 months, i still have throat problems; swelling of throat for 2 months, I still have throat problems; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore of throat for for 2 months, i still have throat problems) and PHARYNGEAL SWELLING (swelling of throat for 2 months, I still have throat problems) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore of throat for for 2 months, i still have throat problems) and PHARYNGEAL SWELLING (swelling of throat for 2 months, I still have throat problems). At the time of the report, OROPHARYNGEAL PAIN (Sore of throat for for 2 months, i still have throat problems) and PHARYNGEAL SWELLING (swelling of throat for 2 months, I still have throat problems) had not resolved. Not Provided          Treatment Information was not reported. Concomitant product information was not reported.
The amount was less than 1/2 of the administered dose; This spontaneous case was reported by a health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (The amount was less than 1/2 of the administered dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (The amount was less than 1/2 of the administered dose). At the time of the report, ACCIDENTAL UNDERDOSE (The amount was less than 1/2 of the administered dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported  No treatment information was provided  Action taken with mRNA-1273 was not applicable
Dry and itchy skin patches over entire body, i.e., lower back, chest, arms, legs, feet, and adjacent to genitals is where it started.
Tingling in her finger tips on the same side of inj; Tingling on her left hand at her finger tips; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PARAESTHESIA (Tingling in her finger tips on the same side of inj) and PARAESTHESIA (Tingling on her left hand at her finger tips) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced INJECTION SITE PARAESTHESIA (Tingling in her finger tips on the same side of inj) and PARAESTHESIA (Tingling on her left hand at her finger tips). At the time of the report, INJECTION SITE PARAESTHESIA (Tingling in her finger tips on the same side of inj) and PARAESTHESIA (Tingling on her left hand at her finger tips) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication was reported.  Treatment medication was not provided by the reporter.
death Narrative: Patient received COVID vaccine # 1 on 1/6/2021, on 1/23/21 his wife reported to the facility that he passed away. Notes in database do not mention cause of death or where death occurred. There are no scanned records in database with any detail either.
Patient reports redness 5-12cm lasting 72 hours.  Mild lump lasting 10 days.  Patient reports headache lasting 4 hours and numbness and or tingling and or burning in arm of shot site.  Considered mild reaction.  Subject states no treatment or medication for reaction.
Pt recv vax on 3/23/99; on same day pt exp tight chest, wheezing
HPV was administered to right arm, and within minutes she passed out, fell to the floor and started twitching, as if having a seizure, was pale, white in color, provider was called to evaluate pt, she was on the floor with her head on mother's knee, getting fanned, EMS was called, was in the upper 90s in O2 and 80s in pulse..EMS arrived she was put on a stretcher and evaluated, she was coherent, speaking and texting, and was put in ambulance and taken to ER.
Patient complained of head pain. Vitals taken and stable. Patient stable after 30 minutes.
Site: Pain at Injection Site-Medium, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Chills-Severe, Systemic: Visual Changes/Disturbances-Severe, Systemic: Vomiting-Severe, Systemic: Weakness-Severe, Additional Details: congestion, brown gunk, trembling, weakness, vivid day dream, taste smell, headache, hallucination, ear audio issues, dry heave,
6pm on the day of vaccination, patient experienced and episode of body aches and shaking. Did not have a fever but felt chilled. Mild tenderness at site but no redness, firmness or swelling. Took 800mg Ibuprofen, fell asleep and woke 4 hours later feeling fine. Symptoms resolved.
I got a fever at night and my arm swelled and rashes up at injection site. The next morning my right shoulder and back of neck swelled up and my lymph nodes on right side of body swelled as well. The back of my head and tongue swelled and was painful.
Breakthrough case admission after 3 vaccines Pfizer 4/26/21 lot# Ew0162;  Pfizer 5/27/21 lot# Ew0172;  Moderna 11/9/21 lot# 067F21A
Vacine received on February 2, 2021.  No side affects until 15 days later on February 17, 2021.  Side affects included swelling and redness in the location of the injection and low grade fever, below 100 degrees.
On day 3 after vaccination patient awoke with cold sores surrounding her mouth. Patient stated she also had a sore in the mouth.  Her PCP  treated her with valtrex 1 gram bid for 1 day.
Very High Fever, (100 F to 106.2 F) (Measured On temple); temperature temporarily goes down with medications then comes back up to very high fever of around 106 F. Swelling of the face, difficulty breathing, weakness. No food intake just fluids.
Patient's first dose was Moderna. When she received her second dose, she was given Pfizer in error.  She did not suffer any adverse events/reactions to the second dose.
fell from the fainting; dizziness; headache which turned into a migraine; Nerve burning; itch; dermatitis; Initial information received on 08-Oct-2020 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional.  This case involves a 62-years-old female patient who fell from the fainting (syncope), itch (pruritus), nerve burning (neuralgia), dermatitis, headache which turned into a migraine (migraine), dizziness, while she received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's ongoing medical history included autoimmune disorder with small fiber neuropathy and skin irritation with two layers of the skin trying to destroy each other that causes irritation on the top of her skin.  The patient's past medical treatment, vaccination and family history were not provided.  On 28-Sep-2020, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number and expiry date not reported via unknown route in the left arm for prophylactic vaccination.  Concomitant medications included PREDNISONE (10 mg every day and has returned to the 10 mg dose after taking the 30 mg the day and symptoms were the worse), DUPILUMAB (DUPIXENT); HEPATITIS B VACCINE, HEPATITIS A VACCINE and VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) for prophylactic vaccination on 02-Oct-2020.  On an unknown date, the patient developed a serious fainting (syncope) unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This event was assessed as medically significant.  In Oct-2020, the patient developed a non-serious itch (pruritus), nerve burning (neuralgia), dermatitis, headache which turned into a migraine (migraine) (5 to 6 hours after DUPIXENT), unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  On an unknown date, the patient developed a non-serious dizziness unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  The intensity of events itch, dermatitis and nerve burning was severe.  Laboratory details were not reported. e It was not reported if the patient received a corrective treatment.  The event outcome was unknown for all events.  Batch number has been requested for suspect product for this case.; Sender's Comments: A 62-years-old female patient who presented with syncope, pruritus, neuralgia, dermatitis, headache progressing to migraine, and dizziness following the vaccination with FLUZONE QUADRIVALENT. Time to onset is not known for syncope and compatible for other events. Medical history include small fiber neuropathy and skin irritation. Patient also had ongoing autoimmune disorder. Concomitant medication include PREDNISONE (symptoms were the worse after triple dose), DUPIXENT, HEPATITIS B VACCINE, HEPATITIS A VACCINE and SHINGRIX. Precise final diagnosis and lab data ruling out alternative etiologies would be needed for complete assessment of the case. Based upon the reported information, role the vaccine cannot be assessed.
Inflammatory reaction at site of smallpox vaccination (swelling, redness, itching, axilla tenderness).
First dose on 3/5/21 in left arm - muscle tenderness & some fatigue.    Second dose given on 3/26/21 in left arm.  Some tenderness in left upper arm.  About a week later (April 1) I had left upper back  & chest pain  (just left of thoracic spine area and forward to left of my sternum bone & left shoulder pain). The area of discomfort increased to under my left armpit. I used Tylenol every 4 hours but still had some pain.  The pain was bad enough that I had trouble sleeping  at night and reaching for objects in my home.  I noticed an "engorged" feeling & tenderness in my left breast.  Swollen lymph nodes were present under my left arm - breast was too tender to check for more lymph nodes.  No fever.  Wasn't sure if I should go to an ER so checked the internet & 4/14/21 Contacted & consulted with my family doctor (Dr - My Chart messages) to let her know.  Found information on Web (internet) that some women are having this kind of reaction in lymph nodes so was less worried about something more serious like a heart attack).  Afternoon of 4/15 and today 4/16 feel the symptoms are beginning to go away - pain in my axilla area is better, lymph nodes not as hard & tender,  left  breast and left side of backbone have decreased discomfort.
Improperly stored doses were administered to the patients; No adverse effect; This spontaneous report was received from a Nurse Practitioner  (NP) concerning several unspecified patients (age and gender not specified). The NP reported that on unspecified dates several doses of improperly stored GARDASIL 9 (lot # M013636, expiration date 15-FEB-2018) (dosage and route not specified) and PROQUAD (lot# M019232, expiration date 17-OCT-2017) (dosage and route not specified) were administered to unspecified patients.  The storage temperature for GARDASIL 9 was -0.1 degrees Celsius for 38 hours, 20 minutes, -1.67 Celsius for 2 minutes, and 9 Celsius for 13 minutes.  The storage temperature for PROQUAD was 11 degrees Fahrenheit for 15 hours 49 minutes.  No adverse effects were reported.  Additional information is not available. On 09-DEC-2016, a call was placed to the NP and went to voice mail.  A message was left requesting a return call from the NP.  Additionally, a request was made for patient identifiers and dates of vaccines. All telephone attempts to obtain follow-up have been unsuccessful. Additional information has been requested. Sender's Comments: MERCK 1610USA002815: Mfr number.
Pt developed a fever of 104.9 and a seizure. He was admitted to the hospital. The patient has gastrointestinal problems, major food and environmental allergies and diagnois of autism.
a substantial amount ran down her arm when administered/may have not gotten half of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (a substantial amount ran down her arm when administered/may have not gotten half of the vaccine) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced UNDERDOSE (a substantial amount ran down her arm when administered/may have not gotten half of the vaccine). On 21-May-2021, UNDERDOSE (a substantial amount ran down her arm when administered/may have not gotten half of the vaccine) had resolved.            Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
The next morning I began to break out in hives. They kept getting worse. I knew it couldn't be from anything I ate, because I can't eat anything but soup, pudding or jello having all my teeth removed.  Today is day 4 and I'm taking benedryl every 3 hours. I've noticed an increase difficulty in breathing and called dr Office today and left message to either prescribe me something for the itchy hives or prescribe cream that can be used on it
her arm was red; This spontaneous case was reported by a non-health professional and describes the occurrence of ERYTHEMA (her arm was red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (her arm was red). At the time of the report, ERYTHEMA (her arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.  It was reported that the patient applied ice to reduce the redness.
On April 06, 2021 this 22 -year-old male patient received the Moderna Covid vaccine on his left deltoid at 1937.  That same evening, the patient complained of pain on his left arm, and received acetaminophen 650 mg by mouth at 21:24.   On April 07, 2021, I spoke with the provider and he stated the patients' pain had resolved.
Patient fainted while sitting in the administration chair. She felt funny, light headed, dizzy prior to fainting.  She was also sweating after she regained consciousness.  She was only unresponsive for about 30 seconds.
Felt exhaustion the following day and evening.; woke up at 1 am with aches pains and a slight fever; woke up at 1 am with aches pains and a slight fever; This is a spontaneous report from a contactable consumer. A 32-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 07Mar2021 (Batch/Lot Number: EN6199) as SINGLE DOSE for covid-19 immunization. Other medical history was none. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Allergies to medications, food, or other products was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications were received within 2 weeks of vaccination. On 22Mar2021 01:00AM, the patient woke up at 1 am with aches pains and a slight fever. Felt exhaustion the following day (23Mar2021) and evening. The patient received second dose of BNT162B2 (Lot number EP6955) via an unspecified route of administration, administered in Arm Left on 28Mar2021 10:30 PM as SINGLE DOSE for covid-19 immunization. The events were assessed as non-serious. No treatment received for the adverse event. Outcome of the events was recovered in 2021.  No follow-up attempts are needed. No further information is expected.